Company Name: Dicerna Pharmaceuticals, Inc.

Dicerna Pharmaceuticals, Inc. is a biopharmaceutical company. The company uses its proprietary RNA interference (RNAi) technology platform to develop treatments for genetically defined cancers and rare inherited liver diseases.

Ticker Symbol: DRNA (NASDAQ)

Company Website: http://dicerna.com

Social Media: Dicerna Pharmaceuticals LinkedIn

Headquarters: Cambridge, Massachusetts